Actively Recruiting
68Ga-NY104 PET/CT Guided Radiation Therapy in CcRCC.
Led by Peking Union Medical College Hospital · Updated on 2024-09-27
40
Participants Needed
1
Research Sites
231 weeks
Total Duration
On this page
Sponsors
P
Peking Union Medical College Hospital
Lead Sponsor
P
Peking University First Hospital
Collaborating Sponsor
AI-Summary
What this Trial Is About
Radiation therapy (RT) is an effective treatment for patients with advanced-stage clear cell renal cell carcinoma (ccRCC). Current evidence has shown promising outcomes combining radiation therapy and standard systemic therapy in patients with metastatic/recurrent ccRCC. CAIX is a highly sensitive and specific biomarker expressed on ccRCC and in previous studies the investigators have shown excellent diagnostic efficacy of 68Ga-NY104, a CAIX-targeted PET tracer, in patients with metastatic ccRCC. In this study, the investigators aim to investigate the effect of 68Ga-NY104, and 18F-FDG PET/CT guided RT combining standard systemic therapy in patients with metastatic ccRCC.
CONDITIONS
Official Title
68Ga-NY104 PET/CT Guided Radiation Therapy in CcRCC.
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 63 18 years old
- Histologically or cytologically confirmed clear cell renal cell carcinoma
- Eligible for radiation therapy with no more than 10 lesions in total
- Expected survival of more than 3 months
- Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1
- Sufficient organ function
- Provided written informed consent
You will not qualify if you...
- Presence of brain metastasis or carcinomatous meningitis
- Other malignant tumors not controlled within the past 5 years, except for non-metastatic low-risk prostate cancer
- Pregnant or breastfeeding
- Active infection
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Peking University First Hospital
Beijing, Beijing Municipality, China, 100034
Actively Recruiting
Research Team
X
Xianshu Gao, MD
CONTACT
M
Mingwei Ma, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here